Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.
Members of Congress who traded INVA
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 1
- Members
- 1
- Buys / sells
- 0 / 2
- Estimated volume
- $450.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| George WhitesidesDemocrat · House · CA | 2 | 0 / 2 | $450.0K | Mar 25, 2025 | Apr 23, 2025 |
Trades
Every reported trade in Innoviva, Inc., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| George WhitesidesDemocrat · House · CA | INVAInnoviva, Inc. - Common Stock | Sell | Self | Mar 24, 2025 | Apr 23, 2025 | 30 days | $50K-$100K | Filing |
| George WhitesidesDemocrat · House · CA | INVAInnoviva, Inc. - Common Stock | Sell | Spouse | Mar 25, 2025 | Apr 23, 2025 | 29 days | $250K-$500K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.